Commonwealth Equity Services, LLC Beam Therapeutics Inc. Transaction History

Commonwealth Equity Services, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	BUY	$23.46 - $45.07 $278,329 - $534,710	11,864 New	11,864 $392,000
Q3 2023 Oct 23, 2023	BUY	$23.01 - $32.46 $23,700 - $33,433	1,030 Added 11.73%	9,812 $236,000
Q2 2023 Aug 10, 2023	BUY	$29.32 - $35.99 $26,769 - $32,858	913 Added 11.6%	8,782 $280,000
Q1 2023 May 11, 2023	BUY	$30.15 - $48.79 $237,250 - $383,928	7,869 New	7,869 $240,000
Q3 2022 Nov 14, 2022	SELL	$39.79 - $70.31 $49,021 - $86,621	-1,232 Reduced 19.55%	5,070 $241,000
Q2 2022 Jul 19, 2022	SELL	$29.86 - $62.36 $56,614 - $118,234	-1,896 Reduced 23.13%	6,302 $243,000
Q1 2022 May 04, 2022	BUY	$53.73 - $82.16 $55,718 - $85,199	1,037 Added 14.48%	8,198 $469,000
Q4 2021 Jan 31, 2022	SELL	$68.02 - $99.06 $41,696 - $60,723	-613 Reduced 7.89%	7,161 $570,000
Q3 2021 Oct 29, 2021	BUY	$84.37 - $133.6 $40,328 - $63,860	478 Added 6.55%	7,774 $676,000
Q2 2021 Aug 11, 2021	BUY	$64.12 - $128.71 $228,716 - $459,108	3,567 Added 95.66%	7,296 $939,000
Q1 2021 May 04, 2021	BUY	$71.28 - $120.75 $63,082 - $106,863	885 Added 31.12%	3,729 $298,000
Q4 2020 Feb 11, 2021	BUY	$22.24 - $95.63 $63,250 - $271,971	2,844 New	2,844 $232,000

236

75.2M

438K

232K

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.78B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.